Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6
- PMID: 21164283
- DOI: 10.1097/PAS.0b013e3182036d05
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6
Abstract
The availability of targeted therapies has created a need for precise subtyping of non-small cell lung carcinomas (NSCLCs). The aim of this study was to assess the utility of immunohistochemical markers in subtyping poorly differentiated NSCLC and to compare the results of immunohistochemical staining on biopsies with the corresponding resections. Thirty-nine cases of NSCLC that could not be further classified on biopsy and had subsequent resection specimens were identified. Classification of the tumor was based on the resection specimen using the World Health Organization criteria. All biopsies and resections were stained with CK7, TTF-1, napsin A (novel aspartic proteinase of the pepsin family), p63, CK5/6, and 34βE12. The specimens included 20 adenocarcinomas (ACs), 15 squamous cell carcinomas (SCCs), and 4 large-cell carcinomas (LCCs). TTF-1 was positive in biopsies from 16 of 20 ACs, 2 of 4 LCCs, and none of the SCCs. p63 was positive in all 15 SCCs, 2 of 20 ACs (both were also positive for TTF-1 and napsin A), and none of the LCCs. CK5/6 was positive in 11 of 15 SCCs (all p63 positive) but none of the ACs or LCCs. Napsin A stained 11 of 19 ACs (all TTF-1 positive) but none of the other tumors. Staining for CK7 was present in 19 of 19 ACs and 9 of 15 SCCs. 34βE12 stained both SCCs (15 of 15) and ACs (12 of 20). The combination of TTF-1, napsin A, p63, and CK5/6 allowed an accurate classification of 30 of39 (77%) cases. Of 232 pairs of slides (biopsy and resection) stained with immunohistochemical markers, 12 (5%) showed discrepancies in immunohistochemical staining between biopsies and their corresponding resections. Immunohistochemical staining using a combination of TTF-1, napsin A, p63, and CK5/6 allows subclassification of poorly differentiated NSCLCs on small lung biopsies in most cases. Discrepancies in immunohistochemical staining between biopsies and resections are uncommon.
Similar articles
-
Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.Lung Cancer. 2012 Apr;76(1):51-5. doi: 10.1016/j.lungcan.2011.09.008. Epub 2011 Oct 5. Lung Cancer. 2012. PMID: 21978426
-
ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.Int J Clin Exp Pathol. 2014 Jun 15;7(7):4247-53. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25120805 Free PMC article.
-
Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4. Ann Diagn Pathol. 2013. PMID: 23040737
-
A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.Int J Surg Pathol. 2009 Jun;17(3):206-18. doi: 10.1177/1066896909336178. Int J Surg Pathol. 2009. PMID: 19443885 Review.
-
What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.Pathology. 2011 Feb;43(2):103-15. doi: 10.1097/PAT.0b013e328342629d. Pathology. 2011. PMID: 21233671 Review.
Cited by
-
Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays.Mol Cell Proteomics. 2013 Sep;12(9):2615-22. doi: 10.1074/mcp.M112.023051. Epub 2013 May 7. Mol Cell Proteomics. 2013. PMID: 23653450 Free PMC article.
-
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.Oncotarget. 2017 Apr 11;8(15):24804-24814. doi: 10.18632/oncotarget.15063. Oncotarget. 2017. PMID: 28177901 Free PMC article.
-
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.Med Sci Monit. 2017 Jan 27;23:489-497. doi: 10.12659/msm.899378. Med Sci Monit. 2017. PMID: 28128193 Free PMC article.
-
Semi-nested real-time reverse transcription polymerase chain reaction methods for the successful quantitation of cytokeratin mRNA expression levels for the subtyping of non-small-cell lung carcinoma using paraffin-embedded and microdissected lung biopsy specimens.Acta Histochem Cytochem. 2013 Apr 30;46(2):85-96. doi: 10.1267/ahc.12024. Epub 2013 Apr 12. Acta Histochem Cytochem. 2013. PMID: 23720607 Free PMC article.
-
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).Clin Transl Oncol. 2012 May;14(5):338-49. doi: 10.1007/s12094-012-0806-2. Clin Transl Oncol. 2012. PMID: 22551539
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous